SM
Sabby Management Portfolio holdings
AUM
$13M
This Quarter Return
+0.61%
1 Year Return
-26.95%
3 Year Return
-56.43%
5 Year Return
-61.92%
10 Year Return
-71.17%
AUM
$357M
AUM Growth
+$357M
(+25,059%)
Cap. Flow
+$144M
Cap. Flow
% of AUM
40.26%
Top 10 Holdings %
Top 10 Hldgs %
39.25%
Holding
232
New
62
Increased
19
Reduced
38
Closed
45
Top Buys
| 1 |
iShares Russell 2000 ETF
IWM
|
$24.7M |
| 2 |
AGN
Allergan plc
AGN
|
$14.4M |
| 3 |
ZGNX
Zogenix, Inc.
ZGNX
|
$11.5M |
| 4 |
MBLY
Mobileye N.V.
MBLY
|
$9.5M |
| 5 |
iShares 20+ Year Treasury Bond ETF
TLT
|
$7.23M |
Top Sells
| 1 |
ACHN
Achillion Pharmaceuticals, Inc.
ACHN
|
$8.78M |
| 2 |
SCTL
Societal CDMO, Inc. Common Stock
SCTL
|
$6.74M |
| 3 |
Adverum Biotechnologies
ADVM
|
$3.56M |
| 4 |
IOC
Interoil Corporation
IOC
|
$3.11M |
| 5 |
Merck
MRK
|
$2.9M |
Sector Composition
| 1 | Healthcare | 63.4% |
| 2 | Technology | 3.74% |
| 3 | Energy | 2.62% |
| 4 | Industrials | 1.07% |
| 5 | Consumer Staples | 0.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CVM.WS
76
DELISTED
Cel-Sci Corp Series S
CVM.WS
| $840K | 0.04% | 2,624,375 -440,370 | -14% | -$141K |
|
77
Talphera
TLPH
$11.1M
| $806K | 0.03% | +208,928 | New | +$806K |
|
78
Madrigal Pharmaceuticals
MDGL
$9.76B
| $794K | 0.03% | +399,000 | New | +$794K |
|
|
CLLS
79
Cellectis
CLLS
$258M
| $785K | 0.03% | +22,700 | New | +$785K |
|
|
BIOL
80
DELISTED
Biolase, Inc.
BIOL
| $760K | 0.03% | +376,000 | New | +$760K |
|
|
NURO
81
DELISTED
NeuroMetrix, Inc. Common Stock
NURO
| $699K | 0.03% | 411,034 +48,160 | +13% | +$81.9K |
|
|
CBAY
82
DELISTED
Cymabay Therapeutics
CBAY
| $692K | 0.03% | 100,000 -800 | -0.8% | -$5.54K |
|
|
CASC
83
DELISTED
Cascadian Therapeutics, Inc.
CASC
| $681K | 0.03% | 417,952 -306,548 | -42% | -$499K |
|
|
VIRX
84
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
| $673K | 0.03% | +274,800 | New | +$673K |
|
85
Imunon
IMNN
$15M
| $616K | 0.03% | 230,699 -222,657 | -49% | -$595K |
|
|
CTIC
86
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
| $600K | 0.03% | 331,627 +86,627 | +35% | +$157K |
|
87
MEI Pharma
MEIP
$160M
| $531K | 0.02% | 296,491 -303,509 | -51% | -$544K |
|
|
IMMU
88
DELISTED
Immunomedics Inc
IMMU
| $528K | 0.02% | +137,751 | New | +$528K |
|
89
TherapeuticsMD
TXMD
$12.8M
| $504K | 0.02% | 83,274 -466,590 | -85% | -$2.82M |
|
90
Arrowhead Research
ARWR
$3.05B
| $502K | 0.02% | +74,204 | New | +$502K |
|
|
NBSE
91
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
| $496K | 0.02% | 195,240 +145,240 | +290% | +$369K |
|
92
Pluri
PLUR
$41.5M
| $490K | 0.02% | +175,000 | New | +$490K |
|
|
RVNC
93
DELISTED
Revance Therapeutics, Inc.
RVNC
| $478K | 0.02% | 23,065 -53,335 | -70% | -$1.11M |
|
94
Esperion Therapeutics
ESPR
$448M
| $463K | 0.02% | +5,000 | New | +$463K |
|
|
ACGN
95
DELISTED
Aceragen, Inc. Common Stock
ACGN
| $438K | 0.02% | +118,000 | New | +$438K |
|
96
Cerus
CERS
$251M
| $417K | 0.02% | +100,000 | New | +$417K |
|
|
BDSI
97
DELISTED
BioDelivery Sciences International, Inc.
BDSI
| $392K | 0.02% | +37,300 | New | +$392K |
|
|
NSPH
98
DELISTED
NANOSPHERE INC. COM NEW
NSPH
| $383K | 0.02% | 1,652,344 -572,737 | -26% | -$133K |
|
99
Sonoma Pharmaceuticals
SNOA
$7.31M
| $352K | 0.01% | +418,792 | New | +$352K |
|
100
Agios Pharmaceuticals
AGIO
$2.19B
| $298K | 0.01% | +3,163 | New | +$298K |
|